Ultragenyx Pharmaceutical Inc. (RARE) Operating cash flow 2016–2025
Ultragenyx Pharmaceutical Inc. (RARE) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$466.0MFY2025 · since FY2016: -$161.0M → -$466.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$466.0M | -12.6% |
| FY2024 | -$414.0M | +12.8% |
| FY2023 | -$475.0M | -24.8% |
| FY2022 | -$380.5M | -12.3% |
| FY2021 | -$338.7M | -156.2% |
| FY2020 | -$132.2M | +61.7% |
| FY2019 | -$345.4M | -18.9% |
| FY2018 | -$290.6M | -14.5% |
| FY2017 | -$253.8M | -57.7% |
| FY2016 | -$161.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice